Transgenic mice are engineered so that on induction they rapidly and predictably develop a disease state that shares major features of advanced vulnerable atherosclerosis in humans. This valuable model is highly suited to studies of cardiovascular drugs which stabilise atherosclerotic plaques and the long term study of arterial diseases such as aneurysm formation, angioplasty restenosis and atherosclerosis.

« Back to all licences